Lilly (Eli) & Co Dividend yield

Lilly (Eli) & Co is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Lilly (Eli) & Co is a company from USA, and his stocks are publicly traded.

Lilly (Eli) & Co stock dividend

Lilly (Eli) & Co paid a total dividend of 4,308 million USD last year, for a market value of 525,936 millions (Market Cap 468,423 millions). Lilly (Eli) & Co dividend per share is 4.54 USD, and his stock market price 554.20 USD.

According to the chart below, where dividend yield is displayed, Lilly (Eli) & Co has a dividend yield of 0.82%, lower than the amount offered by both the market average and companies from USA. It is also lower than average of Health Care industry. This low dividend yield might has several explanations: company overpriced, expanding their business,...

In addition, you should compare Lilly (Eli) & Co stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the best USA dividend stocks list.

Lilly (Eli) & Co Dividend Payout

About the ability of Lilly (Eli) & Co to maintain his current dividend of USD 4.54 per share, an amount that accounts for 0.82%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Lilly (Eli) & Co payout on ernings is currently 63.14%, which is higher than the market average, and companies of Health Care industry, which are 39.34% and 23.54% respectively. Both figures show that Lilly (Eli) & Co can have problems to keep with his present dividend yield.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Lilly (Eli) & Co is USD 7.46 per share, which is higher than the dividend per share paid by the company of USD 4.54, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Lilly (Eli) & Co, compared againt world market average, USA companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Lilly (Eli) & Co Dividend History

Below you will find a table with the historical evolution of Lilly (Eli) & Co's dividend stock, both in percentage and in USD, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).

Year	Yield	USD	Paypout	Shares*
Present	0.82%	4.54	63.14%	949
2022	1.07%	3.91	59.88%	950
2021	1.23%	3.40	49.20%	959
2020	1.75%	2.95	33.03%	957
2019	1.96%	2.58	62.47%	960
2018	1.94%	2.24	99.12%	1,059
2017	2.46%	2.08	66.88%	1,103
2016	3.04%	2.04	74.18%	1,106
2015	2.44%	2.00	76.34%	1,117

*In millions

Then you can see the evolution of Lilly (Eli) & Co dividend stock, and compare it with the average of USA stocks and that of the Pharmaceuticals and Biotechnology stocks.

Lilly (Eli) & Co Stock performance

Finally, last moth Lilly (Eli) & Co showed a return of 21.90% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a 84.00% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for USA and Pharmaceuticals and Biotechnology firms.